InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by MILBY RANDY, Chairman & CEO. Insider active across 1 company, notably Hillstream BioPharma Inc.. In total, 13 disclosures have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €2k. History available since 14 January 2022. The latest transaction was disclosed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
500 shares@ US$0.77990.1% of flowCommon StockSEC:0001493152-22-017377:0
Ideal exit: 14 Mar 2023 (T+270)
234 shares@ US$0.68490.1% of flowCommon StockSEC:0001493152-22-016088:0
Ideal exit: 3 Mar 2023 (T+270)
1 shares@ US$0.940.0% of flowCommon StockSEC:0001493152-22-015724:0
Ideal exit: 26 Feb 2023 (T+270)
200 shares@ US$0.770.1% of flowCommon StockSEC:0001493152-22-015080:0
Ideal exit: 19 Feb 2023 (T+270)
500 shares@ US$0.890.1% of flowCommon StockSEC:0001493152-22-014792:0
Ideal exit: 14 Feb 2023 (T+270)
500 shares@ US$0.91530.2% of flowCommon StockSEC:0001493152-22-014500:0
Ideal exit: 13 Feb 2023 (T+270)
7,575 shares@ US$0.3140.8% of flowCommon StockSEC:0001493152-22-010294:0
8,101 shares@ US$3.2016.0% of flowCommon StockSEC:0001493152-22-001680
27,479 shares@ US$3.2054.4% of flowCommon StockSEC:0001493152-22-001674
14,942 shares@ US$3.2029.6% of flowCommon StockSEC:0001493152-22-001677
27,479 shares@ US$3.2026.8% of flowCommon StockSEC:0001493152-22-001674:0
14,942 shares@ US$3.2014.6% of flowCommon StockSEC:0001493152-22-001677:0
8,101 shares@ US$3.207.9% of flowCommon StockSEC:0001493152-22-001680:0
13 of 13 declarations
About MILBY RANDY
Randy Milby is Chief Executive Officer at Hillstream BioPharma Inc. In this role, he leads the operations and strategy of the company, which focuses on developing innovative treatments. His expertise in biopharmaceuticals is essential to guide the company towards sustainable growth.
